title: In vivo cell-mediated immunity in subjects with undetectable viral load on protease inhibitor-based versus non-protease inhibitor-based highly active antiretroviral therapy.
authors.forename: Jintanat
authors.initials: J
authors.lastname: Ananworanich
authors.forename: Reto
authors.initials: R
authors.lastname: Nuesch
authors.forename: Somsong
authors.initials: S
authors.lastname: Teeratakulpisarn
authors.forename: Preeyaporn
authors.initials: P
authors.lastname: Srasuebkul
authors.forename: Theshinee
authors.initials: T
authors.lastname: Chuenyam
authors.forename: Umaporn
authors.initials: U
authors.lastname: Siangphoe
authors.forename: Chaiwat
authors.initials: C
authors.lastname: Ungsedhaphand
authors.forename: Praphan
authors.initials: P
authors.lastname: Phanuphak
authors.forename: Kiat
authors.initials: K
authors.lastname: Ruxrungtham
mesh_terms: D019380:Anti-HIV Agents / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active; D003430:Cross-Sectional Studies; D015658:HIV Infections / Q000188:drug therapy* / Q000276:immunology; D017320:HIV Protease Inhibitors / Q000627:therapeutic use*; D015497:HIV-1 / Q000276:immunology; D006801:Humans; D006968:Hypersensitivity, Delayed; D007111:Immunity, Cellular; D011446:Prospective Studies; D012367:RNA, Viral / Q000097:blood; D019562:Viral Load
chemical_list: D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D012367:RNA, Viral